|
2025
|
Invention
|
Cyclic polypeptide for the treatment of pha type 1b.
A cyclic polypeptide comprising at least si... |
|
2020
|
Invention
|
Peptide for prevention or treatment of covid-19. 1231233 can be any natural or non-natural amino ... |
|
|
Invention
|
Pharmaceutical composition comprising a cyclic peptide of formula x1-gqretpegaeakpwy-x2 and use f... |
|
|
Invention
|
Composition comprising a peptide and an inhibitor of viral neuraminidase. 3 can be any natural or... |
|
2019
|
Invention
|
Composition comprising a peptide and an inhibitor of viral neuraminidase.
Described is a composi... |
|
2018
|
Invention
|
Method for preventing and treating hyperpermeability. A peptide is described, which consists of 7... |
|
|
Invention
|
Attenuation of intrapulmonary inflammation.
Methods for treating inflammation include administer... |
|
2017
|
Invention
|
Pharmaceutical composition for treatment of the pulmonary form of altitude sickness caused by lac... |
|
2016
|
Invention
|
Cyclic polypeptide for the treatment of pha type 1b. A cyclic polypeptide comprising at least six... |
|
2015
|
Invention
|
Dry-powder peptide medicament. Disclosed is a dry-powder peptide medicament with a non-typical co... |
|
|
Invention
|
Attenuation of intrapulmonary inflammation.
A cyclized compound of the amino acid sequence of fo... |
|
|
Invention
|
Attenuation of intrapulmonary inflammation. A cyclized compound of the amino acid sequence of for... |
|
2014
|
Invention
|
2. Cyclic peptide of formula
2 the C-terminal amino acid in the ultimate, right position, in the... |
|
|
Invention
|
Lyophilisate containing a cyclic peptide of formula x1-gqretpegaeakpwy-x2. A cyclic peptide of fo... |
|
|
Invention
|
Pharmaceutical composition comprising a cyclic peptide of formula x1 -gqretpegaeakpwy-x2 and use ... |
|
|
Invention
|
Method for preventing and treating hyperpermeability.
A peptide is described, which consists of ... |
|
2011
|
Invention
|
Composition comprising a peptide and an inhibitor of viral neuraminidase. Described is a composit... |
|
|
Invention
|
Organic compound for the regulation of vectorial ion channels. A cyclic organic compound which co... |
|
|
Invention
|
Organic compounds for the regulation of vectorial ion channels. A cyclic organic compound w... |
|
|
Invention
|
Cyclic peptides for the regulation of vectorial ion channels. The invention relates to a cyclic o... |
|
2010
|
Invention
|
Treatment of vascular complications of diabetes. 3 can be any natural or non natural amino acid, ... |
|
|
Invention
|
Treatment of vascular complications of diabetes. A peptide consisting of 7-17 amino acids and inc... |
|
|
Invention
|
Method for preventing and treating hyperpermeability. A peptide is described, which consist... |
|
|
Invention
|
Method for preventing and treating hyperpermeability. The invention relates to a peptide consisti... |
|
2009
|
G/S
|
Chemicals used in industry and science. Pharmaceutical preparations. Scientific and technological... |
|
|
G/S
|
Chemicals for use in science and industry. Pharmaceutical products. Scientific and technological ... |
|
2008
|
Invention
|
Cyclic, cystein-free protein. A protein selected from the amino acid sequence of the region valin... |
|
|
Invention
|
Reverse protein. A protein which is composed N-terminally of one or several C-terminal parts of t... |
|
|
Invention
|
Cyclic protein free from cysteines. A protein selected from the amino acid sequence of the ... |
|
|
Invention
|
Cyclic, cystein-free protein. The invention relates to a protein which is selected from the amino... |
|
|
Invention
|
Reverse protein. A protein which is composed N-terminally of one or several C-terminal part... |
|
|
Invention
|
Reverse protein. The invention relates to a protein the N-terminal end of which is composed of on... |
|
2002
|
Invention
|
Tnf-derived peptides for use in treating oedema. 116 to treat pulmonary oedema. For example, the ... |
